ISOTRIFA: Isokinetic Fatigue Index in a Population of Triathletes

Sponsor

Boulogne sur Mer Hospital Center (Other)

Overall Status

Recruiting

CT.gov ID

NCT05635422

Collaborator

(none)

Enrollment

Location

Arm

Anticipated Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the relevance of carrying out a measure of muscular fatigability by isokinetism, in the search for factors favouring micro-traumatic lesions of the lower limbs in a population of triathletes.

This is a prospective monocentric pilot study of the before/after type in which the patient is his or her own control, in high-level triathletes practising an endurance sport, who have had more than 7 consecutive days off running due to a musculoskeletal injury during the previous sporting year.

Condition or Disease	Intervention/Treatment	Phase
Musculoskeletal Diseases	Diagnostic Test: isokinetism test	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

25 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Prevention

Official Title:

Pilot Study to Evaluate an Isokinetic Fatigue Index for Prevention Purposes in a Population of Triathletes

Actual Study Start Date :

Nov 14, 2022

Anticipated Primary Completion Date :

Nov 14, 2024

Anticipated Study Completion Date :

Nov 14, 2024

Arms and Interventions

Arm	Intervention/Treatment
Experimental: isokinetism test in high level triathletes practicing an endurance sport	Diagnostic Test: isokinetism test measure of muscular fatigability by isokinetism

Arm

Intervention/Treatment

Experimental: isokinetism test in high level triathletes practicing an endurance sport

Diagnostic Test: isokinetism test

measure of muscular fatigability by isokinetism

Outcome Measures

Primary Outcome Measures

fatigue index between the injured leg and the healthy leg [the day of inclusion]
To compare the fatigue index between the injured leg and the healthy leg in high level triathletes injured in the previous season.

Secondary Outcome Measures

difference of the fatigue index to the difference of the Croisier ratio between the injured leg and the healthy leg [the day of inclusion]
Correlate the difference in the fatigue index to the difference in the Croisier ratio between the injured leg and the healthy leg.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 40 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Having had a practical running break of more than 7 consecutive days due to a musculoskeletal injury of a lower limb during the previous sport year
Willing to comply with all study procedures
Having given written consent
Socially insured

Exclusion Criteria:

Pain that does not allow an isokinetic test to be performed
Knee joint amplitude less than 100° of flexion or flessum greater than 5°.
History of rupture or ligamentoplasty of the anterior cruciate ligament less than 2 years ago
History of knee surgery less than 2 years

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Boulogne sur mer Hospital Center	Boulogne-sur-Mer		France	62200

Sponsors and Collaborators

Boulogne sur Mer Hospital Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Boulogne sur Mer Hospital Center

ClinicalTrials.gov Identifier:

NCT05635422

Other Study ID Numbers:

2022-01

First Posted:

Dec 2, 2022

Last Update Posted:

Dec 2, 2022

Last Verified:

Nov 1, 2022

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Musculoskeletal Diseases

Study Results

No Results Posted as of Dec 2, 2022